Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Unresectable and Locally-Advanced Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Unresectable Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study
- Status
- RECRUITING
- Phase
- NA
Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Sequential Transarterial Chemoembolization (TACE), Stereotactic Body Radiation Therapy (SBRT), and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma Treated With Donafenib
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Atezolizumab Plus Bevacizumab Combined With Locoregional Therapies in Unresectable Hepatocellular Carcinoma (ISMIO-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study
- Status
- RECRUITING
- Phase
- N/A
Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
HAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
SIRT Versus cTACE for Unresectable HCC (CHANCE2506)
- Status
- RECRUITING
- Phase
- NA
Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
- Status
- RECRUITING
- Phase
- PHASE3
Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
TACE With Thermosensitive Nanogel Versus Embosphere for HCC
- Status
- RECRUITING
- Phase
- NA
"cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4